Keyp

Real-time safety for the therapies of tomorrow

Because every patient story matters. Keyp is a safety intelligence platform that bridges the critical gap between emergency care, trial sites, and sponsors. By capturing real-time adverse events at the point of care, we transform fragmented narratives into structured data keeping patients safer, trials stronger, and sponsors ready for tomorrow’s therapies.

When safety data is delayed, patients pay the price

Current pharmacovigilance workflows miss the earliest signals of harm especially when patients present to emergency departments. Sponsors rely on delayed, manual, and incomplete data capture that leaves blind spots in clinical development and post-marketing safety studies. The result? Slower trials, regulatory risk, higher costs, and most importantly patients left unprotected.

40%

of SAEs missed

In oncology trials, up to 40% of Serious Adverse Events go undetected or are reported late

€350K

per day

Conservative (could be as high as 1M) cost of regulatory holds and trial extensions due to missed safety signals

21%

submission delays

Of trials face regulatory submission delays due to incomplete safety data

One simple system, built for patients, sites, sponsors, and regulators.

Keyp delivers real-time, structured safety data from ED to sponsor protecting patients, empowering sites, and giving sponsors regulatory readiness from day one.

to explore pilots, partnerships, or investment.

Clinicians, Technologists, and Scientists working together for safety

Keyp is founded by a cross-disciplinary team bringing together frontline emergency medicine, oncology, data science, and product design. Together, we are building the missing safety layer for the future of clinical trials.